


| European drug regulator approves Biocon's Malaysia insulin facility |
|
Bengaluru (Karnataka) [India], Aug 22 (ANI): Biopharmaceutical major Biocon said on Thursday said its insulin facility in Malaysia has been approved by the European Medicines Agency. Biocon Sdn Bhd, which operates Asia's largest integrated insulin facility, has received the Certificate of Good Manufacturing Practices.
Posted: 2019-08-22 15:07:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.